Singapore, June 14, 2010: The third edition of BioSpectrum Asia Pacific Survey 2010 is an effort to give a rounded view of the progress the life sciences industry has made. Shenzhen Accord distributes its products in domestic as well as overseas markets. The company has four subsidiaries and one associate.
Rank: 4
Company: Shenzhen Accord Pharmaceutical
Revenue: $1.6 bn
Chairman: Mr Jinming Shi
Business: Research, development, production and sales of pharmaceuticals and medical equipments
Website: www.szaccord.com.cn
Startup Year: 1985
Country: China
Shenzhen Accord Pharmaceutical is engaged in the research, development and production of pharmaceuticals, as well as the wholesale and retail of pharmaceuticals and medical equipments. The company is also involved in the non medicine trading business. The company’s major products include respiratory system anticough drugs and cephalo-type series.
In 2009, the company’s revenue amounted to $1.6 billion. The company offers category III disposable bacterial-free medical treatment instruments; equipment and instruments for operation units, emergency units, and diagnosis units; medical macromolecule materials and products; clinical check up and analysis apparatus, and diagnosis reagents; medical sutures and bonds; oral section materials; and medical assay and basic equipment and instruments. It also provides category II medical electronic equipment, medical X-ray appurtenances and parts, medical ultrasonic instruments and relevant equipments, antisepsis and antibacterial equipments and instruments, and medical sanitation materials and dressings. In addition, the company is involved in the sale of biochemical drugs, psychotropic drugs, blood products,diagnosis drugs, western medicine, health food, and Chinese
herbal pieces.
Further, Shenzhen Accord Pharmaceutical offers warehousing, transportation, cargo package and sorting, and road freight services, as well as provides research, de-velopment, and consultation services for pharmaceutical packaging materials and pharmaceutical industry products. Additionally, it engages in project investment, road transportation of general cargo, property management and leasing, cargo package and sorting, medical information consultancy, and car park management activities, as well as storage, loading, and unloading activities.
The company was formerly known as Shenzhen Health Mineral Water Company and changed its name to Shenzhen Accord Pharmaceutical in June 2001.
Milestones 2009
- Planned to acquire entire share capital of Zhanjiang Tianfeng Pharmaceutical, an owner and operator of pharmacies, from Zheng Xiangdong, Zeng li and Li Shurong.
Related Articles:
APAC life science industry grows 3.4%, clocks $110 bn: BioSpectrum
BioSpectrum Asia Pacific Top 20 Companies:
Rank 1; Rank 2; Rank 3; Rank 4; Rank 5; Rank 6; Rank 7; Rank 8; Rank 9;
Rank 10; Rank 11; Rank 12; Rank 13; Rank 14; Rank 15; Rank 16; Rank 17;
Rank 18; Rank 19; Rank 20
Country analysis: Australian companies step up investments
China: World's largest market exceeds growth forecast
India: Increased healthcare access drives market
Singapore: Investment streams-in
Malaysia: Growth in-step with economic recovery
South Korea: All set for the next level of growth
Taiwan: Home to 14 of Asias fastest companies
|